Aetna, Elevance, and Four Other Insurers Say the Medicare Advantage Star Rating System Is Broken — Now They Are Suing
CVS Health's Aetna subsidiary, along with Elevance Health, SCAN Health Plan, Alignment Healthcare, Healthfirst, and Centene, sued CMS over Medicare Advantage star ratings. They allege CMS used invalid measures, leading to lower ratings and $2B+ in lost bonus payments for Aetna. CMS has not responded. Ratings affect benefits for 4.2M Aetna members and $12.7B in annual bonuses.
How this was made
The 30-second read
Why it matters
The legal actions could depress earnings expectations for the involved insurers and prompt broader sector re‑rating risk assessments.
Market read
First‑report litigation exposing multi‑billion‑dollar risk to leading Medicare Advantage insurers, likely to affect stock valuations and sector sentiment.
What to watch
Potential for settlement or policy change that mitigates the $2 billion exposure.
Background
A coalition of major Medicare Advantage insurers has filed lawsuits alleging that CMS’s star‑rating system is legally flawed, threatening billions in bonus payments.
Ticker impact
CVS Health (owner of Aetna) filed a $2 billion lawsuit over Medicare Advantage star ratings, risking a loss of the same amount in bonus payments.
likely downside as market prices in litigation risk
The lawsuit directly threatens a multi‑billion‑dollar revenue stream; investors typically react negatively to large legal exposures.
Elevance Health joined the star‑rating lawsuits, exposing it to similar $‑billion bonus payment risk.
potential pressure pending outcome of the suits
While the amount is not quantified for Elevance, the legal precedent suggests a material impact.
Centene is among the insurers suing CMS over the star‑rating system, creating exposure to lost bonus payments.
possible downside as market assesses litigation exposure
Centene’s large Medicare Advantage portfolio makes the lawsuit material to its earnings outlook.
Market effects
Medicare Advantage insurers may see heightened scrutiny of CMS star ratings, affecting valuation multiples across the sector.
U.S. health‑care stocks could experience broader volatility as investors reassess regulatory risk.
Limited to U.S. insurers; no direct global spillover beyond multinational health‑care firms.
Counterpoint
If CMS reforms the rating methodology, insurers could ultimately benefit from a more predictable bonus structure.
Key entities
- CompanyCVS Health
Parent of Aetna; plaintiff in the lawsuit.
- CompanyElevance Health
Co‑plaintiff in the star‑rating litigation.
- CompanyCentene
Co‑plaintiff in the star‑rating litigation.
